IROP: IHBT - Development of highly specialized treatment for hematooncological patients

The project"IHBT - development of highly specialized care for hematooncology patients",which is co-financed by the European Union, is underway at IHBT.

Project name: IHBT - development of highly specialized care for hematooncology patients

Registration number: CZ. 06.6.127/0.0/0.0/21_122/0016658

Project objectives: The main objective of the project is the construction of new premises for the applicant IHBT.

The sub-objectives of the project are:

- Reconstruction of the Pavilion of Clinical and Experimental Transfusiology Phase II used for the provision of health services.

- New construction of the Pavilion of Progressive Medicine for the provision of health services.

The object of the project implementation:

Building D - As a result of the extension, new premises will be created, which have been missing so far, such as in the case of cryostorage, which will result in new possibilities in the care of oncology patients, an increase in capacity and resources. Also, in the case of the aforementioned cryostorage, it will lead to autonomy and independence from external entities.

Building A - The reason for the reconstruction of the existing pavilion is to modernize and unify the structural modifications of the building, implementing safety and fire safety features corresponding to the requirements for 21st century buildings. Furthermore, it is the implementation of accessibility in the form of a bed lift, which will allow the connection of the different floors of the building. Last but not least, it is a solution to the layout parameters of the building and more efficient use of the building for the provision of health care. By implementing the project, the entire building will be used as a modern transfusion centre for whole blood and plasma donors, as well as an apheresis centre for platelet donors and patients.

Project implementation: 1 February 2020 to 31 October 2023

The project is co-financed by the European Union as part of the Union's response to the COVID-19 pandemic.